A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy AGE: 18+ HURLEY STAGE: All LOCATION: International View Details
Battlefield Acupuncture for Pain in Hidradenitis Suppurativa AGE: 18+ HURLEY STAGE: All LOCATION: US Only View Details
The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications. AGE: 18+ HURLEY STAGE: All LOCATION: International View Details
Feasibility Study on Radiofrequency-Based Selective Electrothermolysis to Investigate Its Effects on Human Skin AGE: 22-70 HURLEY STAGE: All LOCATION: US Only View Details
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa AGE: 16+ HURLEY STAGE: II & III LOCATION: International View Details
A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab AGE: 18+ SEVERITY: Moderate to Severe LOCATION: US Only View Details
Hidradenitis – an Analysis of Genetic Traits and Linkages in Families AGE: 7+ HURLEY STAGE: All LOCATION: US Only View Details
Intralesional Diode Laser Treatment of Fistulas in Hidradenitis Suppurativa AGE: 18+ HURLEY STAGE: All LOCATION: International View Details
Bacteriophage Therapy for Difficult-to-treat Infections: the Implementation of a Multidisciplinary Phage Task Force AGE: 7+ HURLEY STAGE: All LOCATION: International View Details
Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa AGE: 18+ SEVERITY: Moderate to Severe LOCATION: International View Details